基本信息
views: 255
Career Trajectory
Bio
主要从事高分子药物载体,特别是核酸药物载体方面的研究,以通讯作者在Nature Nanotechnology、Nature Communications、Advanced Materials、National Science Review、Advanced Functional Materials、ACS Nano、Nano Letters等发表论文70多篇,论文被引用1万余次;主持基金委联合基金重点项目、优秀青年基金、面上项目、广东省杰出青年基金等,参与863计划、国家重点研发计划、广东省“珠江人才计划”创新团队等项目。获2019年中国生物材料学会科学技术奖二等奖、2020年安徽省科学技术奖二等奖、2021年度广东省自然科学奖一等奖。
Research Interests
Papers共 153 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Xiaowan Huang,Ziyang Cao,Jieying Qian,Tao Ding, Yanxia Wu,Hao Zhang,Suqin Zhong,Xiaoli Wang, Xiaoguang Ren,Wang Zhang,Youcui Xu,Guangyu Yao,Xingwu Wang,Xianzhu Yang,Longping Wen,Yunjiao Zhang
NATURE NANOTECHNOLOGYno. 4 (2024)
Nano Lettersno. 4 (2024): 1376-1384
Chaoran Chen,Yuxi Zhang,Ziyang Cao,Dongdong Li,Yueqiang Zhu, Houjin Jing,Yan Li,Fangzheng Li,Cong-Fei Xu,Xianzhu Yang,Jun Wang
ADVANCED FUNCTIONAL MATERIALSno. 44 (2024)
Li Peng,Yanyi Jiang,Hengxing Chen, Yongqiang Wang,Qiusheng Lan, Shuiqin Chen,Zhanwang Huang,Jingyuan Zhang,Duanqing Tian,Yuntan Qiu,Diankui Cai,Jiangyun Peng,Daning Lu,Xiaoqing Yuan,Xianzhu Yang,Dong Yin
ACTA PHARMACEUTICA SINICA Bno. 5 (2024): 2119-2136
Science China Materialspp.1-15, (2024)
BIOMATERIALS SCIENCEno. 8 (2024): 2057-2066
Yi Zhang, Mingjie Wang,Ling Ye,Shengqi Shen,Yuxi Zhang,Xiaoyu Qian,Tong Zhang,Mengqiu Yuan,Zijian Ye, Jin Cai, Xiang Meng,Shiqiao Qiu, Shengzhi Liu,Rui Liu,Weidong Jia,Xianzhu Yang,Huafeng Zhang,Xiuying Zhong,Ping Gao
Science China Technological Sciencesno. 8 (2024): 2350-2362
NANO LETTERSno. 29 (2024): 9017-9026
Load More
Author Statistics
#Papers: 154
#Citation: 9216
H-Index: 49
G-Index: 95
Sociability: 6
Diversity: 3
Activity: 134
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn